PRCT

Procept Biorobotics Corp

• Benzinga·1d ago

  PROCEPT BioRobotics Announces Two Milestones In Its WATER IV Prostate Cancer Clinical Program

• Reuters·1d ago

  PROCEPT BIOROBOTICS® ADVANCES PROSTATE CANCER PROGRAM WITH WATER IV STUDY ENROLLMENT COMPLETION AND EXPANDED IDE APPROVAL

• TipRanks·05/14 16:46

  Aquablation Gains Stronger Guideline Backing, Supporting Procept’s Long-Term Growth and Buy Rating

• TipRanks·05/14 15:35

  PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen

• TipRanks·05/13 10:50

  Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), PROCEPT BioRobotics (PRCT) and Lineage Therap (LCTX)

• TipRanks·05/04 19:50

  Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Incyte (INCY)

• TipRanks·05/01 00:47

  Procept Biorobotics Charts Growth Amid Profit Pressures

• PUBT·04/30 22:10

  Procept BioRobotics EVP, CTO Barry Templin files initial beneficial ownership statement

• PUBT·04/30 20:10

  Procept BioRobotics to present at Bank of America Health Care Conference

• Benzinga·04/30 17:18

  Piper Sandler Reiterates Overweight on PROCEPT BioRobotics, Raises Price Target to $35

• TipRanks·04/30 13:40

  Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Teva Pharmaceutical (TEVA) and PROCEPT BioRobotics (PRCT)

• TipRanks·04/30 12:51

  Procept BioRobotics price target raised to $35 from $28 at Piper Sandler

• Benzinga·04/30 12:06

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• TipRanks·04/30 11:50

  Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), AbbVie (ABBV) and Humana (HUM)

• TipRanks·04/30 11:04

  Piper Sandler Keeps Their Buy Rating on PROCEPT BioRobotics (PRCT)